Replimune Group, Inc. (REPL)

2.17 -0.02 (-0.91%) USD  |  NASDAQ  |  Apr 17, 16:00
2.16 -0.01 (-0.46%) After-Hours: 20:00
More

Replimune Group Price Target Upside (Daily)

Price Target Upside (Daily) Chart

View Price Target Upside (Daily) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Upside (Daily) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Upside (Daily) Range, Past 5 Years

View Price Target Upside (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Upside (Daily) Benchmarks

View Price Target Upside (Daily) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade